Tag:
Xifaxan
Latest Headlines
Latest Headlines
FDA officially denies IBD indication for Salix drug
Salix Pharmaceuticals didn't win the FDA's blessing to market Xifaxan as a remedy for irritable bowel syndrome, a potentially lucrative new use for the drug, which is now approved for traveler's
FDA 'sucker punches' Salix with Xifaxan denial
Salix Pharmaceuticals took a body blow from FDA, as the agency refused to broaden use of its bowel drug Xifaxan. Widely expected to win an indication for use in irritable bowel syndrome, Xifaxan is
Salix shares surge on Xifaxan approval
Shares of Raleigh, NC-based Salix Pharmaceuticals got a nice bounce after the FDA approved its drug Xifaxan for recurrent hepatic encephalopathy, a disease that can trigger memory loss, confusion and
Salix wins FDA panel backing on Xifaxan
Shares of Salix reversed course in after-market trading yesterday evening, shooting up after the developer handily won an FDA expert panel vote backing the safety and efficacy of Xifaxan 550 mg
Salix braces for harsh panel review of Xifaxan
Salix Pharmaceuticals is headed for its scheduled showdown today with a panel of FDA experts who are expected to grill the company on Xifaxan (rifaximin), a drug that is being prepped for the hepatic
Who's up for a big FDA approval decision in the first half?
Few events can move a biotech stock quite like an FDA decision on a new drug app. And given the agency's rep for somewhat unpredictable behavior, there's no such thing as a sure thing. All of which
